IL13 and COVID-19: In a prospective cohort by Lawrence et al, children with MIS-C exhibited significantly higher IL-6, IL-8, IL-10, and IL-13 levels than the acute COVID-19 cohort, and these elevations paralleled increased cardiac and systemic inflammation markers such as CRP and pro-BNP [53].